Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1475 Neoplasms 996 Colorectal Neoplasms 830 Carcinoma, Non-Small-Cell Lung 724 Carcinoma, Hepatocellular 682 Stomach Neoplasms 646 Lung Neoplasms 583 Prostatic Neoplasms 543 Pancreatic Neoplasms 457 Rectal Neoplasms 338 Uterine Cervical Neoplasms 303 Colonic Neoplasms 295 Neoplasm Metastasis 289 Ovarian Neoplasms 285 Esophageal Neoplasms 279 Recurrence 276 Leukemia, Myeloid, Acute 253 Head and Neck Neoplasms 240 Multiple Myeloma 232 Brain Neoplasms 203 Polycystic Ovary Syndrome 200 Nasopharyngeal Carcinoma 198 Melanoma 198 Precursor Cell Lymphoblastic Leukemia-Lymphoma 195 Urinary Bladder Neoplasms 191 Lymphoma 178 Liver Neoplasms 178 Endometrial Neoplasms 159 Motor Activity 147 Lymphoma, Large B-Cell, Diffuse 140

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Safety Issues × Clear all

NCT03620435 2018-08-13

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Unknown

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon ⚡